Stocks
Amylyx Pharmaceuticals (AMLX) EBITDA margin US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | |||
| EBITDA margin, % | ? | -6 001% | -903.5% | 10.5% | -333.0% | |||
| Changes by years, y/y, % | -6 079pp | +6 001pp | +914pp | -344pp | ||||
Amylyx Pharmaceuticals. EBITDA margin, %
Amylyx Pharmaceuticals. EBITDA margin, changes, pp
Amylyx Pharmaceuticals (AMLX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | LTM ? | |||
| EBITDA margin, % | ? | 2.06% | -137.4% | -5 203% | -18 135% | -6 089% | ||
| Changes by years, y/y, % | +205pp | -135pp | -5 224pp | -18 153pp | -6 091pp | |||
| Changes by quarters, q/q, % | -16pp | -139pp | -5 066pp | -12 932pp | +12 045pp | |||
